CLINICAL_TRIALS
trial_result
· 2017-03-13
Clinical Trial Update: Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma [Phase 2]
Summary
A Phase 2 clinical trial is evaluating metronomic chemotherapy for metastatic osteosarcoma, with the current status listed as UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Grupo de Apoio ao Adolescente e a Crianca com Cancer | Conditions: Osteosarcoma | Phase 2 | Status: UNKNOWN